Renaissance Technologies (RenTech)'s IMMX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 258,600 shares of Immix Biopharma, Inc. (IMMX) worth $1.35 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in IMMX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 237,100 shares. Largest reduction occurred in Q3 2024, reducing 154,685 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Immix Biopharma (IMMX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immix Biopharma (IMMX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +237,100 | Add 1102.79% | 258,600 | $5.23 |
| Q3 2025 | +21,500 | New Buy | 21,500 | $2.09 |
| Q3 2024 | -154,685 | Sold Out | 0 | $0.00 |
| Q2 2024 | -110,815 | Reduce 41.74% | 154,685 | $1.98 |
| Q1 2024 | +233,100 | Add 719.44% | 265,500 | $3.07 |
| Q4 2023 | +32,400 | New Buy | 32,400 | $6.91 |
| Q3 2023 | -10,600 | Sold Out | 0 | $0.00 |
| Q2 2023 | +10,600 | New Buy | 10,600 | $0.00 |
| Q4 2022 | -27,050 | Sold Out | 0 | $0.00 |
| Q3 2022 | +27,050 | New Buy | 27,050 | $1.37 |
| Q2 2022 | -62,600 | Sold Out | 0 | $0.00 |
| Q1 2022 | +62,600 | New Buy | 62,600 | $2.41 |
Renaissance Technologies (RenTech)'s Immix Biopharma Investment FAQs
Renaissance Technologies (RenTech) first purchased Immix Biopharma, Inc. (IMMX) in Q1 2022, acquiring 62,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Immix Biopharma, Inc. (IMMX) for 12 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Immix Biopharma, Inc. (IMMX) was in Q4 2025, adding 258,600 shares worth $1.35 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 258,600 shares of Immix Biopharma, Inc. (IMMX), valued at approximately $1.35 M.
As of the Q4 2025 filing, Immix Biopharma, Inc. (IMMX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Immix Biopharma, Inc. (IMMX) was 265,500 shares, as reported at the end of Q1 2024.